MedTrace Logo

Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients

NCT05638893 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-12-07

No results posted yet for this study

Summary

This study aims to evaluate the possible efficacy and safety of addition of metformin to celecoxib in patients with knee osteoarthritis.

Conditions

Interventions

DRUG

Placebo Tablet

Placebo (tablet/12hr) + celecoxib (200mg/day) for three months.

DRUG

Metformin Hcl 500Mg Tab

Metformin (500mg/12hr) + celecoxib (200mg/day) for three months.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sahar M El-Haggar, Professor · Tanta University

  • Amal M El-Barbary, Professor · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-03-12
Completion
2022-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638893 on ClinicalTrials.gov